{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:16:48Z","timestamp":1793755008577,"version":"4.6.1"},"reference-count":81,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/deed.en_GB"}],"content-domain":{"domain":["eje.bioscientifica.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,2]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Hereditary hypophosphatemias (HH) are rare monogenic conditions characterized by decreased renal tubular phosphate reabsorption. The aim of this study was to explore the prevalence, genotypes, phenotypic spectrum, treatment response, and complications of treatment in the Norwegian population of children with HH.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Retrospective national cohort study.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      Sanger sequencing and multiplex ligand-dependent probe amplification analysis of\n                      <jats:italic>PHEX<\/jats:italic>\n                      and Sanger sequencing of\n                      <jats:italic>FGF23<\/jats:italic>\n                      ,\n                      <jats:italic>DMP1<\/jats:italic>\n                      ,\n                      <jats:italic>ENPP1<\/jats:italic>\n                      <jats:italic>KL<\/jats:italic>\n                      , and\n                      <jats:italic>FAM20C<\/jats:italic>\n                      were performed to assess genotype in patients with HH with or without rickets in all pediatric hospital departments across Norway. Patients with hypercalcuria were screened for\n                      <jats:italic>SLC34A3<\/jats:italic>\n                      mutations. In one family, exome sequencing was performed. Information from the patients' medical records was collected for the evaluation of phenotype.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Twety-eight patients with HH (18 females and ten males) from 19 different families were identified. X-linked dominant hypophosphatemic rickets (XLHR) was confirmed in 21 children from 13 families. The total number of inhabitants in Norway aged 18 or below by 1st January 2010 was 1\u200a109\u200a156, giving an XLHR prevalence of \u223c1 in 60\u200a000 Norwegian children.\n                      <jats:italic>FAM20C<\/jats:italic>\n                      mutations were found in two brothers and\n                      <jats:italic>SLC34A3<\/jats:italic>\n                      mutations in one patient. In XLHR, growth was compromised in spite of treatment with oral phosphate and active vitamin D compounds, with males tending to be more affected than females. Nephrocalcinosis tended to be slightly more common in patients starting treatment before 1 year of age, and was associated with higher average treatment doses of phosphate. However, none of these differences reached statistical significance.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We present the first national cohort of HH in children. The prevalence of XLHR seems to be lower in Norwegian children than reported earlier.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1530\/eje-15-0515","type":"journal-article","created":{"date-parts":[[2015,11,5]],"date-time":"2015-11-05T22:19:31Z","timestamp":1446761971000},"page":"125-136","update-policy":"https:\/\/doi.org\/10.1530\/crossmarkpolicy-1","source":"Crossref","is-referenced-by-count":157,"title":["Hereditary hypophosphatemia in Norway: a retrospective population-based study of genotypes, phenotypes, and treatment complications"],"prefix":"10.1093","volume":"174","author":[{"given":"Silje","family":"Rafaelsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helge","family":"R\u00e6der","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Bjerknes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","reference":[{"key":"2015120919143135000_174.2.125.1","doi-asserted-by":"publisher","DOI":"10.1007\/s00774-011-0340-2"},{"key":"2015120919143135000_174.2.125.2","doi-asserted-by":"publisher","DOI":"10.1359\/JBMR.0301264"},{"key":"2015120919143135000_174.2.125.3","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.101545198"},{"key":"2015120919143135000_174.2.125.4","doi-asserted-by":"crossref","unstructured":"Drezner MK Lyles KW Haussler MR Harrelson JM . Evaluation of a role for 1,25-dihydroxyvitamin D3 in the pathogenesis and treatment of X-linked hypophosphatemic rickets and osteomalacia. Journal of Clinical Investigation 1980 66 1020\u20131032. (doi:10.1172\/JCI109930).","DOI":"10.1172\/JCI109930"},{"key":"2015120919143135000_174.2.125.5","doi-asserted-by":"publisher","DOI":"10.1038\/ng1095-130"},{"key":"2015120919143135000_174.2.125.6","doi-asserted-by":"publisher","DOI":"10.1038\/81664"},{"key":"2015120919143135000_174.2.125.7","doi-asserted-by":"publisher","DOI":"10.1038\/ng1868"},{"key":"2015120919143135000_174.2.125.8","doi-asserted-by":"publisher","DOI":"10.1038\/ng1905"},{"key":"2015120919143135000_174.2.125.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2010.01.010"},{"key":"2015120919143135000_174.2.125.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2010.01.006"},{"key":"2015120919143135000_174.2.125.11","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.1850"},{"key":"2015120919143135000_174.2.125.12","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1402218111"},{"key":"2015120919143135000_174.2.125.13","doi-asserted-by":"crossref","unstructured":"Wang X Wang S Li C Gao T Liu Y Rangiani A Sun Y Hao J George A Lu Y . Inactivation of a novel FGF23 regulator, FAM20C, leads to hypophosphatemic rickets in mice. PLoS Genetics 2012 8 e1002708. (doi:10.1371\/journal.pgen.1002708).","DOI":"10.1371\/journal.pgen.1002708"},{"key":"2015120919143135000_174.2.125.14","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0712361105"},{"key":"2015120919143135000_174.2.125.15","doi-asserted-by":"publisher","DOI":"10.1086\/499409"},{"key":"2015120919143135000_174.2.125.16","doi-asserted-by":"publisher","DOI":"10.1086\/499410"},{"key":"2015120919143135000_174.2.125.17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197209072871003"},{"key":"2015120919143135000_174.2.125.18","doi-asserted-by":"publisher","DOI":"10.1530\/EC-13-0103"},{"key":"2015120919143135000_174.2.125.19","doi-asserted-by":"publisher","DOI":"10.3109\/03014460.2012.759276"},{"key":"2015120919143135000_174.2.125.20","doi-asserted-by":"publisher","DOI":"10.1258\/0004563001901371"},{"key":"2015120919143135000_174.2.125.21","doi-asserted-by":"crossref","unstructured":"Morey M Castro-Feijoo L Barreiro J Cabanas P Pombo M Gil M Bernabeu I Diaz-Grande JM Rey-Cordo L Ariceta G . Genetic diagnosis of X-linked dominant hypophosphatemic rickets in a cohort study: tubular reabsorption of phosphate and 1,25(OH)2D serum levels are associated with PHEX mutation type. BMC Medical Genetics 2011 12 116. (doi:10.1186\/1471-2350-12-116).","DOI":"10.1186\/1471-2350-12-116"},{"key":"2015120919143135000_174.2.125.22","unstructured":"Statistics Norway. (https:\/\/www.ssb.no\/statistikkbanken\/selectout\/ShowTable.asp?FileformatId=2&Queryfile=20151120125141735872111NY3026&PLanguage=0&MainTable=NY3026&potsize=36 Accession date Nov.4th 2015)."},{"key":"2015120919143135000_174.2.125.23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2003-030036"},{"key":"2015120919143135000_174.2.125.24","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0383"},{"key":"2015120919143135000_174.2.125.25","doi-asserted-by":"crossref","unstructured":"Davies M Stanbury SW . The rheumatic manifestations of metabolic bone-disease. Clinics in Rheumatic Diseases 1981 7 595\u2013646.","DOI":"10.1016\/S0307-742X(21)00372-6"},{"key":"2015120919143135000_174.2.125.26","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-08-0818"},{"key":"2015120919143135000_174.2.125.27","unstructured":"Graham JB Mc FV Winters RW . Familial hypophosphatemia with vitamin D-resistant rickets. II: three additional kindreds of the sex-linked dominant type with a genetic analysis of four such families. American Journal of Human Genetics 1959 11 311\u2013332."},{"key":"2015120919143135000_174.2.125.28","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-009-0631-z"},{"key":"2015120919143135000_174.2.125.29","doi-asserted-by":"publisher","DOI":"10.1038\/jhg.2012.56"},{"key":"2015120919143135000_174.2.125.30","doi-asserted-by":"crossref","unstructured":"Abe Y Nagasaki K Watanabe T Abe T Fukami M . Association between compound heterozygous mutations of SLC34A3 and hypercalciuria. Hormone Research in Paediatrics 2014 82 65\u201371. (doi:10.1159\/000360291).","DOI":"10.1159\/000360291"},{"key":"2015120919143135000_174.2.125.31","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2013101085"},{"key":"2015120919143135000_174.2.125.32","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/6.4.539"},{"key":"2015120919143135000_174.2.125.33","doi-asserted-by":"crossref","unstructured":"Song HR Park JW Cho DY Yang JH Yoon HR Jung SC . PHEX gene mutations and genotype\u2013phenotype analysis of Korean patients with hypophosphatemic rickets. Journal of Korean Medical Science 2007 22 981\u2013986. (doi:10.3346\/jkms.2007.22.6.981).","DOI":"10.3346\/jkms.2007.22.6.981"},{"key":"2015120919143135000_174.2.125.34","doi-asserted-by":"publisher","DOI":"10.1203\/01.PDR.0000169983.40758.7B"},{"key":"2015120919143135000_174.2.125.35","doi-asserted-by":"publisher","DOI":"10.1210\/jc.86.8.3889"},{"key":"2015120919143135000_174.2.125.36","doi-asserted-by":"publisher","DOI":"10.1210\/jc.83.10.3459"},{"key":"2015120919143135000_174.2.125.37","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-1528"},{"key":"2015120919143135000_174.2.125.38","doi-asserted-by":"crossref","unstructured":"Pekkinen M Laine CM Makitie R Leinonen E Lamberg-Allardt C Viljakainen H Makitie O . FGF23 gene variation and its association with phosphate homeostasis and bone mineral density in Finnish children and adolescents. Bone 2015 71 124\u2013130. (doi:10.1016\/j.bone.2014.10.013).","DOI":"10.1016\/j.bone.2014.10.013"},{"key":"2015120919143135000_174.2.125.39","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(64)90085-3"},{"key":"2015120919143135000_174.2.125.40","doi-asserted-by":"crossref","unstructured":"Reid IR Hardy DC Murphy WA Teitelbaum SL Bergfeld MA Whyte MP . X-linked hypophosphatemia: a clinical, biochemical, and histopathologic assessment of morbidity in adults. Medicine 1989 68 336\u2013352. (doi:10.1097\/00005792-198911000-00002).","DOI":"10.1097\/00005792-198911000-00002"},{"key":"2015120919143135000_174.2.125.41","unstructured":"Winters RW Mc FV Graham JB . Genetic studies of vitamin D resistant rickets and familial hypophosphatemia. Helvetica Paediatrica Acta 1959 14 533\u2013538."},{"key":"2015120919143135000_174.2.125.42","doi-asserted-by":"crossref","unstructured":"Hardy DC Murphy WA Siegel BA Reid IR Whyte MP . X-linked hypophosphatemia in adults: prevalence of skeletal radiographic and scintigraphic features. Radiology 1989 171 403\u2013414. (doi:10.1148\/radiology.171.2.2539609).","DOI":"10.1148\/radiology.171.2.2539609"},{"key":"2015120919143135000_174.2.125.43","doi-asserted-by":"publisher","DOI":"10.1210\/jc.81.11.4075"},{"key":"2015120919143135000_174.2.125.44","unstructured":"Shields ED Scriver CR Reade T Fujiwara TM Morgan K Ciampi A Schwartz S . X-linked hypophosphatemia: the mutant gene is expressed in teeth as well as in kidney. American Journal of Human Genetics 1990 46 434\u2013442."},{"key":"2015120919143135000_174.2.125.45","doi-asserted-by":"publisher","DOI":"10.1067\/mpd.2003.119"},{"key":"2015120919143135000_174.2.125.46","doi-asserted-by":"crossref","unstructured":"Quinlan C Guegan K Offiah A Neill RO Hiorns MP Ellard S Bockenhauer D Hoff WV Waters AM . Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment. Pediatric Nephrology 2012 27 581\u2013588. (doi:10.1007\/s00467-011-2046-z).","DOI":"10.1007\/s00467-011-2046-z"},{"key":"2015120919143135000_174.2.125.47","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2009-1671"},{"key":"2015120919143135000_174.2.125.48","doi-asserted-by":"crossref","unstructured":"Reiss E Canterbury JM Bercovitz MA Kaplan EL . The role of phosphate in the secretion of parathyroid hormone in man. Journal of Clinical Investigation 1970 49 2146\u20132149. (doi:10.1172\/JCI106432).","DOI":"10.1172\/JCI106432"},{"key":"2015120919143135000_174.2.125.49","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.090509"},{"key":"2015120919143135000_174.2.125.50","doi-asserted-by":"publisher","DOI":"10.1172\/JCI72829"},{"key":"2015120919143135000_174.2.125.51","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-1551"},{"key":"2015120919143135000_174.2.125.52","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(87)80245-7"},{"key":"2015120919143135000_174.2.125.53","doi-asserted-by":"publisher","DOI":"10.1136\/adc.65.10.1125"},{"key":"2015120919143135000_174.2.125.54","doi-asserted-by":"publisher","DOI":"10.1007\/BF00860736"},{"key":"2015120919143135000_174.2.125.55","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199112263252604"},{"key":"2015120919143135000_174.2.125.56","unstructured":"Kooh SW Binet A Daneman A . Nephrocalcinosis in X-linked hypophosphataemic rickets: its relationship to treatment, kidney function, and growth. Clinical and Investigative Medicine. M\u00e9decine Clinique et Experimentale 1994 17 123\u2013130."},{"key":"2015120919143135000_174.2.125.57","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(05)81957-2"},{"key":"2015120919143135000_174.2.125.58","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(99)70060-0"},{"key":"2015120919143135000_174.2.125.59","doi-asserted-by":"publisher","DOI":"10.1210\/jc.78.6.1378"},{"key":"2015120919143135000_174.2.125.60","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80951-1"},{"key":"2015120919143135000_174.2.125.61","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(72)80298-1"},{"key":"2015120919143135000_174.2.125.62","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2014.316"},{"key":"2015120919143135000_174.2.125.63","doi-asserted-by":"publisher","DOI":"10.1677\/JOE-07-0267"},{"key":"2015120919143135000_174.2.125.64","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.340"},{"key":"2015120919143135000_174.2.125.65","unstructured":"Alon US Monzavi R Lilien M Rasoulpour M Geffner ME Yadin O . Hypertension in hypophosphatemic rickets \u2013 role of secondary hyperparathyroidism. Pediatric Nephrology 2003 18 155\u2013158. (doi:10.1007\/s00467-002-1044-6)."},{"key":"2015120919143135000_174.2.125.66","doi-asserted-by":"crossref","unstructured":"Sun GE Suer O Carpenter TO Tan CD Li-Ng M . Heart failure in hypophosphatemic rickets: complications from high-dose phosphate therapy. Endocrine Practice 2013 19 e8\u2013e11. (doi:10.4158\/EP12184.CR).","DOI":"10.4158\/EP12184.CR"},{"key":"2015120919143135000_174.2.125.67","unstructured":"Andrews RG Baumhardt H Martin B Belachew D Reyes-Mugica M . Oral manifestations of hyperparathyroidism secondary to familial hypophosphatemic rickets. Pediatric Dentistry 2014 36 422\u2013424."},{"key":"2015120919143135000_174.2.125.68","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2265.2003.01685.x"},{"key":"2015120919143135000_174.2.125.69","unstructured":"Tournis S Georgoulas T Zafeiris C Papalexis C Petraki K Lyritis GP . Tertiary hyperparathyroidism in a patient with X-linked hypophosphatemic rickets. Journal of Musculoskeletal & Neuronal Interactions 2011 11 266\u2013269."},{"key":"2015120919143135000_174.2.125.70","doi-asserted-by":"crossref","unstructured":"Neal MD Deslouches B Ogilvie J . The use of pre-operative imaging and intraoperative parathyroid hormone level to guide surgical management of tertiary hyperparathyroidism from X-linked hypophosphatemic rickets: a case report. Cases Journal 2009 2 7572. (doi:10.4076\/1757-1626-2-7572).","DOI":"10.4076\/1757-1626-2-7572"},{"key":"2015120919143135000_174.2.125.71","doi-asserted-by":"crossref","unstructured":"McHenry CR Mostafavi K Murphy TA . Tertiary hyperparathyroidism attributable to long-term oral phosphate therapy. Endocrine Practice 2006 12 294\u2013298. (doi:10.4158\/EP.12.3.294).","DOI":"10.4158\/EP.12.3.294"},{"key":"2015120919143135000_174.2.125.72","doi-asserted-by":"publisher","DOI":"10.1001\/archsurg.139.2.218"},{"key":"2015120919143135000_174.2.125.73","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.39.468"},{"key":"2015120919143135000_174.2.125.74","unstructured":"Moreno Molina JA Lopez Siguero JP Bueno Fernandez A Martinez-Aedo Ollero MJ Martinez Valverde A . Tertiary hyperparathyroidism during the treatment of familial hypophosphatemic rickets. Anales Espa\u00f1oles de Pediatr\u00eda 1996 45 193\u2013195."},{"key":"2015120919143135000_174.2.125.75","doi-asserted-by":"crossref","unstructured":"Knudtzon J Halse J Monn E Nesland A Nordal KP Paus P Seip M Sund S Sodal G . Autonomous hyperparathyroidism in X-linked hypophosphataemia. Clinical Endocrinology 1995 42 199\u2013203. (doi:10.1111\/j.1365-2265.1995.tb01863.x).","DOI":"10.1111\/j.1365-2265.1995.tb01863.x"},{"key":"2015120919143135000_174.2.125.76","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.04981107"},{"key":"2015120919143135000_174.2.125.77","unstructured":"Grove-Laugesen D Rejnmark L . Three-year successful cinacalcet treatment of secondary hyperparathyroidism in a patient with X-linked dominant hypophosphatemic rickets: a case report. Case Reports in Endocrinology 2014 2014 479641. (doi:10.1155\/2014\/479641)."},{"key":"2015120919143135000_174.2.125.78","doi-asserted-by":"crossref","unstructured":"Yavropoulou MP Kotsa K Gotzamani Psarrakou A Papazisi A Tranga T Ventis S Yovos JG . Cinacalcet in hyperparathyroidism secondary to X-linked hypophosphatemic rickets: case report and brief literature review. Hormones 2010 9 274\u2013278. (doi:10.14310\/horm.2002.1277).","DOI":"10.14310\/horm.2002.1277"},{"key":"2015120919143135000_174.2.125.79","unstructured":"US Food and Drug Administration. Sensipar (cinacalcet hydrochloride): drug safety communication. FDA suspends pediatric clinical trials after report of death: US Food and Drug Administration, 2013. (http:\/\/www.fda.gov\/Safety\/MedWatch\/SafetyInformation\/SafetyAlertsforHumanMedicalProducts\/ucm341255.htm Accession date Nov.4th 2015)."},{"key":"2015120919143135000_174.2.125.80","doi-asserted-by":"crossref","unstructured":"Carpenter TO Olear EA Zhang JH Ellis BK Simpson CA Cheng D Gundberg CM Insogna KL . Effect of paricalcitol on circulating parathyroid hormone in X-linked hypophosphatemia: a randomized, double-blind, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2014 99 3103\u20133111. (doi:10.1210\/jc.2014-2017).","DOI":"10.1210\/jc.2014-2017"},{"key":"2015120919143135000_174.2.125.81","doi-asserted-by":"crossref","unstructured":"Imel EA Carpenter TO . A practical clinical approach to paediatric phosphate disorders. Endocrine Development 2015 28 134\u2013161. (doi:10.1159\/000381036).","DOI":"10.1159\/000381036"}],"container-title":["European Journal of Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/174\/2\/125.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/eje.bioscientifica.com\/view\/journals\/eje\/174\/2\/125.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T11:32:57Z","timestamp":1676374377000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ejendo\/article\/174\/2\/125\/6655490"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":81,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1530\/eje-15-0515","relation":{},"ISSN":["0804-4643","1479-683X"],"issn-type":[{"value":"0804-4643","type":"print"},{"value":"1479-683X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2]]}}}